G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $827,000 | -3.9% | 49,821 | +10.9% | 0.00% | 0.0% |
| Q4 2018 | $861,000 | -80.7% | 44,935 | -47.2% | 0.00% | -66.7% |
| Q3 2018 | $4,454,000 | +152.2% | 85,174 | +109.6% | 0.00% | +50.0% |
| Q2 2018 | $1,766,000 | +93.9% | 40,643 | +65.3% | 0.00% | +100.0% |
| Q1 2018 | $911,000 | +232.5% | 24,580 | +77.9% | 0.00% | – |
| Q4 2017 | $274,000 | +15.1% | 13,818 | +44.6% | 0.00% | – |
| Q3 2017 | $238,000 | – | 9,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |